Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  doxycycline
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Doxycycline In Lymphangioleiomyomatosis (LAM)
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07061, NCT00989742
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065154, E-8592, NCCTG-942853, NCI-P96-0076, NCT00002872
Doxycycline, Temozolomide and Ipilimumab in Melanoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-1165, NCI-2014-01836, NCT01590082
A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML20829, NCT00531934
A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: IELSG27, EudraCT number 2006-005795-41, NCT01010295
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and
Sponsor: Other
Protocol IDs: AIO-LQ-0110, 2010-022938-85, NCT01668498
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RC09C8, NCI-2012-01275, NCT01867294
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 8 and over
Sponsor: NCI
Protocol IDs: 060198, 06-C-0198, NCT00353158
Start Over